These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21252)

  • 41. Study of the action of 4-aminopyridine on the isolated vas deferens of the guinea-pig.
    Benoist JM; Lemeignan M; Lechat P
    Pharmacology; 1969; 2(3):151-60. PubMed ID: 5388131
    [No Abstract]   [Full Text] [Related]  

  • 42. Chlorpromazine metabolism. VI. Adrenolytic and antiserotonergic activities of chlorpromazine and its various metabolites.
    Kaul PN; Pabrai PR; Farmer M
    Arch Int Pharmacodyn Ther; 1973 Dec; 206(2):325-37. PubMed ID: 4149789
    [No Abstract]   [Full Text] [Related]  

  • 43. Smooth muscle relaxant properties and vasomotor actions of 2-amino-1-p-nitrophenylpropane-1,3-diol.
    Banerjee S; Mitra C; Mukherjee AK
    J Pharm Sci; 1977 Sep; 66(9):1239-41. PubMed ID: 903858
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Steric aspects of adrenegic drugs. XV. Use of isomeric activity ratio as a criterion to differentiate adrenergic receptors.
    Patil PN; Patel DG; Krell RD
    J Pharmacol Exp Ther; 1971 Mar; 176(3):622-33. PubMed ID: 4398742
    [No Abstract]   [Full Text] [Related]  

  • 45. [Mechanism of catecholamine release in the excised guinea pig vas deferens, with special reference to the role of acetylcholine].
    Takikita A
    Nihon Yakurigaku Zasshi; 1972 Jul; 68(4):385-99. PubMed ID: 4676296
    [No Abstract]   [Full Text] [Related]  

  • 46. Adrenergic beta receptors in vas deferens.
    Ganguly DK; Bhattacharya BB
    Arch Int Pharmacodyn Ther; 1970 Jun; 185(2):406-12. PubMed ID: 4394397
    [No Abstract]   [Full Text] [Related]  

  • 47. Potent alpha-adrenoceptor action of soterenol on vascular and other smooth muscle.
    Kitagawa H; Yamauchi A; Shibata S
    Eur J Pharmacol; 1975 Aug; 33(1):227-30. PubMed ID: 240730
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhancement of noradrenaline responses by thyrotropine-releasing hormone.
    Cuenca E; Serrano MI; Gibert-Rahola J; Galiana J
    J Pharm Pharmacol; 1975 Mar; 27(3):199-200. PubMed ID: 238005
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of dopaminoceptor agonists and antagonists on the rat vas deferens "in vitro".
    Tayo FM
    West Afr J Pharmacol Drug Res; 1979; 5(1):45-53. PubMed ID: 555128
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Log-normal distribution of equiefective doses of norepinephrine and acetylcholine in several tissues.
    Fleming WW; Westfall DP; De la Lande IS; Jellett LB
    J Pharmacol Exp Ther; 1972 May; 181(2):339-45. PubMed ID: 5063989
    [No Abstract]   [Full Text] [Related]  

  • 51. A conformational study of beta-phenethanolamine receptor sites. 8. Pharmacological study of 3-isopropylamino-2-phenyl-trans-2-decalols.
    Hava M; Bernstein J; Smissman EE; El-Antably S
    J Med Chem; 1976 Jan; 19(1):52-4. PubMed ID: 1246053
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hyperthyroid induced changes in adrenergic receptor status in guinea pig vas deferens.
    Ahuja GB; Goyal RK; Verma SC
    Indian J Exp Biol; 1983 May; 21(5):272-4. PubMed ID: 6667979
    [No Abstract]   [Full Text] [Related]  

  • 53. Mode of action of 5-hydroxytryptamine on isolated rat vas deferens.
    Nishino K; Irikura T; Takayanagi I
    Nature; 1970 Nov; 228(5271):564-5. PubMed ID: 5472479
    [No Abstract]   [Full Text] [Related]  

  • 54. Presynaptic agonist effect of phentolamine in the rabbit vas deferens and rat cerebral cortex.
    Ennis C; Lattimer N
    J Pharm Pharmacol; 1984 Nov; 36(11):753-7. PubMed ID: 6150979
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effects of Cd2+ on the responsiveness of the rat anococcygenus muscle and vas deferens to electrical stimulation, noradrenaline, tyramine and K+ [proceedings].
    Fadloun Z; Leach GD
    Br J Pharmacol; 1979 Jul; 66(3):495P. PubMed ID: 526764
    [No Abstract]   [Full Text] [Related]  

  • 56. [Effect of cinobufagin on the guinea pig vas deferens and its mechanism of action].
    Han YJ; Zhang L; Cui RF
    Yao Xue Xue Bao; 1992; 27(4):252-5. PubMed ID: 1442037
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is epinephrine reversal a phenomenon purely of -adrenergic block?
    Kaul CL; Grewal RS
    Arch Int Pharmacodyn Ther; 1970 Aug; 186(2):363-78. PubMed ID: 4399726
    [No Abstract]   [Full Text] [Related]  

  • 58. [Studies on the mechanism of action of angiotensin on the isolated aorta preparation and on the blood pressure of rats and guinea pigs].
    Schümann HJ; Güther W
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 256(2):169-82. PubMed ID: 4298878
    [No Abstract]   [Full Text] [Related]  

  • 59. Haloperidol inhibits contractions of the vas deferens.
    Stone TW
    J Pharm Pharmacol; 1977 May; 29(5):312-3. PubMed ID: 17701
    [No Abstract]   [Full Text] [Related]  

  • 60. Responsiveness of the guinea-pig vas deferens to phenylephrine and norepinephrine in vivo.
    Sannomiya P; De Moraes S
    Eur J Pharmacol; 1977 Nov; 46(1):59-62. PubMed ID: 923651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.